Vogiatzis I, Sdogkos E, Pliatsika M, Papadopoulos A, Spahiu A, Roditis P
Department of Cardiology, General Hospital of Veroia, Veroia, Greece.
Hippokratia. 2023 Jan-Mar;27(1):18-21.
Hospitalizations of patients with atrial fibrillation (AF) lead to an explosion of expenditure on the public health system or private health expenses in family budgets. This study aims to estimate the duration and the cost of hospitalization for the public health system or the private cost to patients hospitalized after an AF episode.
Two hundred thirty-five consecutive patients (141 men and 94 women with an average age of 71.91 ± 12.2 years) who presented with AF to the Emergency Department of the General Hospital of Veroia during a single year were studied. We assessed the possible causes of arrhythmia, the duration and outcome of hospitalization, and the cost of hospitalization. We estimated the total cost by adding the price of the drugs used to cardiovert and the money spent on the patient's hospitalization.
The average hospitalization time was 2.37 ± 1.17 days, and the average cost of hospitalization (total cost) was € 488.22 ± 170.34. There was a significant correlation between the severity of the episode and the total cost (r =0.78, p<0.0001), with 87.6 % of the total cost (€ 427.76 ± 135.86) being related to the cost of hospitalization (imaging, laboratory, hospitalization) and the rest to the drug therapy cost. Amiodarone (97 patients, 41.1 %), flecainide (52 patients, 22 %), propafenone (68 patients, 28.8 %), vernakalant (two patients, 0.8 %), and quinidine (eight patients, 3.4 %) were utilized.
The average cost of hospital care in patients with AF is significantly related to the severity of the episode. Effective drug therapy to reduce AF-provoking factors, such as antihypertensive therapy, combined with cardiovascular disease prevention in general, could reduce the morbidity and costs of AF-related hospitalizations. HIPPOKRATIA 2023, 27 (1):18-21.
房颤（AF）患者的住院治疗导致公共卫生系统支出激增，或使家庭预算中的私人医疗费用大幅增加。本研究旨在估算公共卫生系统的住院时长及费用，或房颤发作后住院患者的私人费用。
对某一年在韦里亚总医院急诊科就诊的235例连续房颤患者（141例男性和94例女性，平均年龄71.91±12.2岁）进行了研究。我们评估了心律失常的可能原因、住院时长及结局，以及住院费用。我们通过将用于复律的药物价格与患者住院费用相加来估算总成本。
平均住院时间为2.37±1.17天，平均住院费用（总成本）为488.22±170.34欧元。发作严重程度与总成本之间存在显著相关性（r = 0.78，p<0.0001），总成本的87.6%（427.76±135.86欧元）与住院费用（影像检查、实验室检查、住院费）相关，其余与药物治疗费用相关。使用了胺碘酮（97例患者，41.1%）、氟卡尼（52例患者，22%）、普罗帕酮（68例患者，28.8%）、维纳卡兰（2例患者，0.8%）和奎尼丁（8例患者，3.4%）。
房颤患者的平均住院护理费用与发作严重程度显著相关。有效的药物治疗以减少诱发房颤的因素，如抗高血压治疗，并结合总体心血管疾病预防措施，可降低房颤相关住院的发病率和费用。《希波克拉底》2023年，27(1):18 - 21。
